ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS • Currently down 0.47 (-2.07%) in today's trading session

Track congressional stock trades in ACADIA Pharmaceuticals Inc. (ACAD). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

ACADIA Pharmaceuticals Inc. is currently trading at $22.20, positioned at 57% of its 52-week range ($14.20 – $28.35).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$22.20
24h Change
-0.47 (-2.07%)
52 Week Range
$14.20—$28.35
View on NASDAQ

ACADIA Pharmaceuticals Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ACAD

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.78B

Volume

1.28M

Beta

0.83

P/E Ratio

9.65

Fundamentals

EPS

$2.30

Div. Yield

—

Open

$22.36

Day Range

$22.01 — $22.73

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Catherine E. Owen Adams
IPO Date
2004-05-27
Website
www.acadia-pharm.com

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for th...

Earnings

Next Report

Q1 2026

6 May

EPS Est.

$0.04

Rev. Est.

$280M

Days Until

6

Recent Quarters

Q4 202525 Feb
EPS$1.60
Beat 1067.9%
Q3 20255 Nov
EPS$0.26
Beat 85.7%
Q2 20256 Aug
EPS$0.16
Beat 14.3%
Q1 20257 May
EPS$0.11
Beat 10.0%
Q4 202426 Feb
EPS$0.17
Beat 30.8%
Q3 20246 Nov
EPS$0.20
Beat 42.9%
Q2 20246 Aug
EPS$0.20
Beat 11.1%
Q1 20248 May
EPS$0.10
Beat 100.0%
Q4 202327 Feb
EPS$0.28
Miss 6.7%
Q3 20232 Nov
EPS$-0.40
Beat 7.0%
Q2 20232 Aug
EPS$0.01
Beat 108.3%
Q1 20238 May
EPS$-0.27
Miss 28.6%
Q4 202227 Feb
EPS$-0.26
Miss 4.0%
Q3 20222 Nov
EPS$-0.17
Beat 5.6%
Q2 20228 Aug
EPS$-0.21
Beat 16.0%
Q1 20224 May
EPS$-0.70
Miss 42.9%
Q4 202128 Feb
EPS$-0.27
Miss 12.5%
Q3 20218 Nov
EPS$-0.09
Beat 66.7%
Q2 20214 Aug
EPS$-0.27
Beat 10.0%
Q1 20215 May
EPS$-0.42
Beat 20.8%
Q4 202024 Feb
EPS$-0.42
Beat 12.5%
Q3 20204 Nov
EPS$-0.54
Miss 42.1%
Q2 20205 Aug
EPS$-0.27
Beat 38.6%
Q1 20207 May
EPS$-0.57
Miss 23.9%
Q4 201926 Feb
EPS$-0.34
Beat 8.1%
Q3 201930 Oct
EPS$-0.29
Beat 29.3%
Q2 201931 Jul
EPS$-0.38
Beat 17.4%
Q1 20191 May
EPS$-0.59
Miss 9.3%
Q4 201826 Feb
EPS$-0.50
Beat 9.1%
Q3 20186 Nov
EPS$-0.50
Beat 13.8%
Q2 20188 Aug
EPS$-0.51
Miss 13.3%
Q1 20184 May
EPS$-0.44
Beat 21.4%
Q4 201727 Feb
EPS$-0.55
Beat 5.2%
Q3 20177 Nov
EPS$-0.53
Beat 15.9%
Q2 20178 Aug
EPS$-0.55
Beat 22.5%
Q1 20179 May
EPS$-0.72
Beat 1.4%
Q4 201628 Feb
EPS$-0.65
Beat 0.0%
Q3 20167 Nov
EPS$-0.61
Miss 8.9%
Q2 20164 Aug
EPS$-0.63
Miss 31.3%
Q1 20165 May
EPS$-0.45
Miss 12.5%
Q4 201529 Feb
EPS$-0.45
Miss 21.6%
Q3 20155 Nov
EPS$-0.39
Beat 2.5%
Q2 20156 Aug
EPS$-0.39
Miss 30.0%
Q1 20157 May
EPS$-0.40
Miss 60.0%
Q4 201426 Feb
EPS$-0.28
Miss 12.0%
Q3 201410 Nov
EPS$-0.25
Miss 19.1%
Q2 20145 Aug
EPS$-0.18
Miss 5.9%
Q1 20146 May
EPS$-0.19
Miss 46.1%
Q4 201327 Feb
EPS$-0.13
Beat 0.0%
Q3 20136 Nov
EPS$-0.12
Beat 0.0%
Q2 20136 Aug
EPS$-0.11
Miss 22.2%
Q1 20137 May
EPS$-0.08
Beat 0.0%
Q4 201212 Mar
EPS$-0.11
Miss 37.5%
Q3 20125 Nov
EPS$-0.04
Beat 50.0%
Q2 20128 Aug
EPS$-0.10
Beat 16.7%
Q1 20128 May
EPS$-0.12
Miss 9.1%
Q4 20116 Mar
EPS$-0.10
Beat 0.0%
Q3 20119 Nov
EPS$-0.10
Beat 0.0%
Q2 201110 Aug
EPS$-0.12
Beat 14.3%
Q1 201110 May
EPS$-0.12
Miss 9.1%
Q4 201010 Mar
EPS$0.74
Beat 7.3%
Q3 20109 Nov
EPS$-0.11
Beat 35.3%
Q2 20109 Aug
EPS$-0.11
Beat 31.3%
Q1 201010 May
EPS$-0.14
Beat 17.6%
Q4 20099 Mar
EPS$-0.20
Miss 5.3%
Q3 20099 Nov
EPS$-0.23
Beat 4.2%
Q2 20095 Aug
EPS$-0.34
Beat 0.0%
Q1 200911 May
EPS$-0.40
Miss 11.1%
Q4 20089 Mar
EPS$-0.38
Miss 2.7%
Q3 20085 Nov
EPS$-0.42
Beat 6.7%
Q2 20085 Aug
EPS$-0.49
Miss 6.5%
Q1 20085 May
EPS$-0.44
Beat 4.3%
Q4 20075 Mar
EPS$-0.46
Beat 0.0%
Q3 20075 Nov
EPS$-0.43
Miss 13.2%
Q2 20076 Aug
EPS$-0.29
Beat 25.6%
Q1 20078 May
EPS$-0.42
Beat 2.3%
Q4 20066 Mar
EPS$-0.42
Beat 4.5%
Q3 20066 Nov
EPS$-0.38
Beat 5.0%
Q2 20068 Aug
EPS$-0.43
Miss 19.4%
Q1 200610 May
EPS$-0.39
Miss 11.4%
Q4 20051 Mar
EPS$-0.44
Miss 15.8%
Q3 200510 Nov
EPS$-0.53
Miss 76.7%
Q2 200510 Aug
EPS$-0.26
Beat 10.3%
Q1 200511 May
EPS$-0.31
Beat 22.5%
Q4 20043 Mar
EPS$-0.44
Miss 7.3%
Q3 200410 Nov
EPS$-0.37
Beat 0.0%
Q2 200412 Aug
EPS$-0.90
Q2 200411 Aug
EPS$-0.42
Beat 36.4%
Q3 200331 Dec
EPS$-2.36
Q2 200330 Sept
EPS$-0.31
Q1 200330 Jun
EPS$-2.04
Q4 200231 Mar
EPS$-2.34

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.